The earliest practical pregnancy test, the Aschheim-Zondek test discussed in our article on hCG history, involved injecting a woman's urine into immature female mice and observing whether ovarian changes occurred, a process that took several days and required maintaining live laboratory animals.
This approach was refined over subsequent years into variations using rabbits and, later, South African clawed frogs, all working on the same underlying principle: that hCG in a pregnant woman's urine would trigger a detectable biological response in the test animal. The rabbit variant became common enough that it lent its name to the popular phrase associated with pregnancy testing for decades, even after rabbits stopped being used.
The major turning point came with the development of immunoassay techniques in the mid-twentieth century, which used antibodies designed to bind specifically to hCG rather than relying on a live animal's biological response. This eliminated the need for laboratory animals entirely and dramatically shortened the time needed to get a result.
Early immunoassays still required laboratory equipment and trained personnel, so testing remained something performed by a clinic or lab rather than something a person could do at home, but the accuracy and speed improvements over the animal bioassay era were substantial.
This era also introduced quantitative measurement of hCG concentration as a routine laboratory capability, which is what eventually made the trend-based monitoring described in our article on diagnosing pregnancy with beta-hCG possible in ordinary clinical practice rather than a research curiosity.
Home pregnancy testing became possible once immunoassay technology was simplified into a format that did not require laboratory equipment to interpret, allowing a person to test a urine sample privately without visiting a clinic. This shift, which took hold from the 1970s onward, was a major change in how and when people could access pregnancy information.
These home tests are qualitative, discussed in our article on diagnosing pregnancy with beta-hCG, meaning they report a positive or negative result based on whether hCG is present above a set threshold, rather than reporting an exact concentration.
Since the emergence of home testing, refinements have focused on increasing sensitivity, allowing detection of lower hCG concentrations earlier in pregnancy, and on improving how results are communicated, including digital displays that show a plain-language result rather than requiring interpretation of test lines.
Despite all of this technological change, the underlying biological target has never changed: every method described in this article, from the 1920s mouse assay to a modern digital test, is built around detecting the same hormone, hCG, whose biology is discussed in our article on hCG in early pregnancy.
This history illustrates something worth appreciating: pregnancy testing did not require discovering a new biological signal at each stage, only better and faster ways of detecting the same one first identified in the 1920s. REVIVE LAB UAE provides this history for general educational interest and does not sell, stock, or supply hCG or any pregnancy testing product.